+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Systemic Mastocytosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Systemic Mastocytosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Graves Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Graves Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Allergic Rhino-Conjunctivitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Allergic Rhino-Conjunctivitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Febrile Neutropenia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Febrile Neutropenia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chemotherapy Induced Febrile Neutropenia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chemotherapy Induced Febrile Neutropenia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Lymphedema - Epidemiology Forecast - 2032 - Product Thumbnail Image

Lymphedema - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Perennial Allergic Rhinitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Perennial Allergic Rhinitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Steroid Refactory Acute Graft-Versus-Host Disease (GVHD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Steroid Refactory Acute Graft-Versus-Host Disease (GVHD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Inclusion Body Myositis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Inclusion Body Myositis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Cutaneous Lupus Erythematosus (CLE) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Cutaneous Lupus Erythematosus (CLE) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Acute Graft-versus-host Disease - Epidemiology Forecast - 2032 - Product Thumbnail Image

Acute Graft-versus-host Disease - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Allergic Fungal Rhinosinusitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Allergic Fungal Rhinosinusitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Autoimmune Gastritis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Autoimmune Gastritis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Graft Versus Host Disease (GvHD) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Graft Versus Host Disease (GvHD) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Allergic Conjunctivitis - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Allergic Conjunctivitis - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Immune Thrombocytopenia (ITP) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Immune Thrombocytopenia (ITP) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Tadekinig Alfa - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Tadekinig Alfa - Emerging Insight and Market Forecast - 2030

  • Report
  • April 2021
  • 35 Pages
  • Global
From
HYQVIA - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

HYQVIA - Emerging Insight and Market Forecast - 2030

  • Report
  • February 2021
  • 30 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more